Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
99,823,000
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
3,108,475
-
Shares change
-
-345,309
-
Total reported value, excl. options
-
$11,809,884
-
Value change
-
-$1,252,441
-
Put/Call ratio
-
13%
-
Number of buys
-
13
-
Number of sells
-
12
-
Price
-
$3.80
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) as of Q2 2024
As of 30 Jun 2024 Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,108,475 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, Alphabet Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, TAKEDA PHARMACEUTICAL CO LTD, GEODE CAPITAL MANAGEMENT, LLC, STIFEL FINANCIAL CORP, BANK OF AMERICA CORP /DE/, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This table shows 43 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.